Reaction Details Report a problem with these data
Target
Cytoplasmic tyrosine-protein kinase BMX
Ligand
BDBM50236074
Substrate
n/a
Meas. Tech.
ChEMBL_1658703 (CHEMBL4008315)
IC50
2823±n/a nM
Citation
 Liang, X; Lv, F; Wang, B; Yu, K; Wu, H; Qi, Z; Jiang, Z; Chen, C; Wang, A; Miao, W; Wang, W; Hu, Z; Liu, J; Liu, X; Zhao, Z; Wang, L; Zhang, S; Ye, Z; Wang, C; Ren, T; Wang, Y; Liu, Q; Liu, J Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor. J Med Chem 60:1793-1816 (2017) [PubMed]  Article 
Target
Name:
Cytoplasmic tyrosine-protein kinase BMX
Synonyms:
BMX | BMX non-receptor tyrosine kinase | BMX_HUMAN | Bone marrow tyrosine kinase gene in chromosome X protein | Cytoplasmic tyrosine-protein kinase BMX (BMX) | ETK | Epithelial and endothelial tyrosine kinase | NTK38 | Tyrosine Kinase BMX | Tyrosine-protein kinase BMX/ETK
Type:
Tyrosine-protein kinase
Mol. Mass.:
78030.42
Organism:
Homo sapiens (Human)
Description:
P51813
Residue:
675
Sequence:
MDTKSILEELLLKRSQQKKKMSPNNYKERLFVLTKTNLSYYEYDKMKRGSRKGSIEIKKIRCVEKVNLEEQTPVERQYPFQIVYKDGLLYVYASNEESRSQWLKALQKEIRGNPHLLVKYHSGFFVDGKFLCCQQSCKAAPGCTLWEAYANLHTAVNEEKHRVPTFPDRVLKIPRAVPVLKMDAPSSSTTLAQYDNESKKNYGSQPPSSSTSLAQYDSNSKKIYGSQPNFNMQYIPREDFPDWWQVRKLKSSSSSEDVASSNQKERNVNHTTSKISWEFPESSSSEEEENLDDYDWFAGNISRSQSEQLLRQKGKEGAFMVRNSSQVGMYTVSLFSKAVNDKKGTVKHYHVHTNAENKLYLAENYCFDSIPKLIHYHQHNSAGMITRLRHPVSTKANKVPDSVSLGNGIWELKREEITLLKELGSGQFGVVQLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKQPYDLYDNSQVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH
  
Inhibitor
Name:
BDBM50236074
Synonyms:
CHEMBL4078199
Type:
Small organic molecule
Emp. Form.:
C32H34F3N7O3
Mol. Mass.:
621.6527
SMILES:
CN1C(=O)N(Cc2cnc(Nc3ccc(C)c(NC(=O)C=C)c3)nc12)c1cc(NC(=O)[C@H]2CC[C@@H](CC2)C(F)(F)F)ccc1C |r,wU:31.33,wD:34.40,(73.75,-22.65,;73.76,-21.11,;75.1,-20.34,;76.44,-21.11,;75.1,-18.8,;73.77,-18.02,;72.45,-18.79,;71.13,-18.01,;69.79,-18.77,;69.78,-20.31,;68.44,-21.08,;68.43,-22.62,;67.08,-23.37,;67.07,-24.91,;68.41,-25.7,;68.4,-27.24,;69.75,-24.92,;71.09,-25.7,;72.43,-24.92,;72.43,-23.38,;73.75,-25.7,;73.73,-27.24,;69.76,-23.38,;71.1,-21.09,;72.43,-20.33,;76.43,-18.03,;77.77,-18.8,;79.11,-18.03,;80.45,-18.8,;81.78,-18.03,;81.78,-16.49,;83.11,-18.79,;84.43,-18.02,;85.76,-18.79,;85.76,-20.33,;84.43,-21.09,;83.11,-20.33,;87.09,-21.1,;88.42,-20.33,;87.08,-22.63,;88.41,-21.86,;79.1,-16.48,;77.77,-15.71,;76.43,-16.49,;75.1,-15.71,)|
Structure:
Search PDB for entries with ligand similarity: